Tech Moves: Meta leader for Pacific NW steps down; Phase Genomics adds to C-suite Paresh Rajwat this summer stepped down from his role as the Pacific Northwest head of office for Meta, which has… Read More
Tech Moves: Sana R&D chief steps down; Seattle U names new computer science leader Seattle University named Dr. Burkhard Englert as the new Department Chair and Amazon Endowed Chair of Computer Science. Englert is… Read More
Tech Moves: Adaptive Biotechnologies COO departing; Sana adds leaders; and more — Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies, the company said today in a regulatory… Read More
Sana Biotechnology will cut 15% of its workforce in latest layoffs affecting Seattle companies Seattle-based cell and gene therapy company Sana Biotechnology will reduce its workforce by 15%, according to a statement issued Tuesday.… Read More
Sana Biotechnology to build manufacturing facility in Seattle area, switching from California After announcing plans last summer to build its manufacturing facility in California, Sana Biotechnology has changed course. The cell and… Read More
Biotech stocks are getting crushed — but industry insiders say there’s reason for optimism Biotech is coming off an epic few years. The sector soared during the pandemic, with venture capital investment and IPO… Read More
Juno Therapeutics vets Steve Harr and Hans Bishop on building startups, working with tech, and more Hans Bishop and Steve Harr know a few things about biotech. The pair once worked together at Seattle flagship cell… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Biotech companies fuel IPO boom in Washington state over the past year In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped… Read More
Seattle biotech startup Sana Biotechnology will develop 163K square-foot facility in the Bay Area Sana Biotechnology, a young and fast-growing Seattle-based biotech, has chosen the San Francisco Bay Area as the site for its… Read More
Univ. of Washington and Sana researchers use gene editing to prep stem cells for heart repair Human stem cell scientists have long dreamed of repairing damaged hearts, but have been stymied by research showing that the cells… Read More
Sana Biotechnology boosts IPO range, looks to raise $517 million Editor’s note: Sana Biotechnology priced shares on Wednesday evening, raising $587.5 million. See full story here. Sana Biotechnology —… Read More
Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body Less than three years after it was founded and with no revenue on the books, Sana Biotechnology filed to go… Read More
Play Episode Podcast GeekWire Podcast: What Seattle’s billion-dollar startups say about the region’s tech industry Play Here’s what we’re talking about on the GeekWire Podcast this week: Seattle’s tech community just reached a new milestone: 10… Read More
Seattle area boasts 10 fast-growing unicorns: Can you name the billion-dollar startups? The unicorn — that supposed elusive creature of the startup world — is becoming a bit more commonplace in these… Read More
Play Episode Podcast GeekWire Podcast: What pandemic? Tech funding stays strong; Accolade’s IPO; Future of sports Play Here’s what we’re talking about on the GeekWire Podcast this week. Despite the pandemic, funding for Pacific Northwest tech startups… Read More
Vote for Health Innovation of the Year: Tech and life sciences unite at the 2020 GeekWire Awards Editor’s note: The GeekWire Awards are now virtual on July 23. Watch live below. Technology is increasingly influencing the science… Read More
Former Juno execs unveil Sana, a new cell engineering biotech that’s reportedly raising more than $800M Former Juno Therapeutics executives Hans Bishop and Steve Harr have launched Sana Biotechnology, a startup focused on cell therapy, gene… Read More
